|
Market Closed -
Nasdaq
16:00:00 2026-10-27 EDT
|
5-day change | 1st Jan Change | ||
| 38.03 USD | +3.20% |
|
+3.79% | +39.71% |
| 09-21 | BofA Securities Adjusts Agios Pharmaceuticals Price Target to $50 From $46, Maintains Buy Rating | MT |
| 07-30 | Agios Pharmaceuticals, Inc., Q2 2026 Earnings Call, Jul 30, 2026 |
| Market Cap | 2.27B 2.04B 1.88B 1.71B 3.19B 216B 3.23B 22.56B 8.96B 113B 8.52B 8.34B 358B | P/E 2026 * |
-6.6x | P/E 2027 * | -10.1x |
|---|---|---|---|---|---|
| Enterprise Value | 2.14B 1.92B 1.77B 1.61B 3B 203B 3.04B 21.23B 8.43B 106B 8.02B 7.85B 337B | EV / Sales 2026 * |
12.1x | EV / Sales 2027 * | 6.52x |
| Free-Float |
77.8% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AGIO | Delayed | |
CBOE
| AGIO | Real-time | |
|
Deutsche Boerse AG
| 8AP | Delayed | |
|
Tradegate
| 8AP | Real-time | |
|
Börse Stuttgart
| 8AP | Delayed | |
|
Boerse Muenchen
| 8AP | Real-time | |
|
Berne S.E.
| 8AP | End-of-day quote |
Last Transcript: Agios Pharmaceuticals, Inc.
| 1 day | +3.20% | ||
| 1 week | +3.79% | ||
| Current month | +14.38% | ||
| 1 month | +16.73% | ||
| 3 months | +2.87% | ||
| 6 months | +55.67% | ||
| Current year | +39.71% |
| 1 week | 36.1 |  | 38.13 |
| 1 month | 29.67 | | 38.13 |
| Current year | 24.29 | | 44.09 |
| 1 year | 22.24 | | 46 |
| 3 years | 20.04 | | 62.58 |
| 5 years | 16.75 | | 62.58 |
| 10 years | 16.75 | | 99.82 |
| Manager | Title | Age | Since |
|---|---|---|---|
Brian Goff
CEO | Chief Executive Officer | 57 | 2022-08-07 |
Cecilia Jones
DFI | Director of Finance/CFO | 51 | 2022-09-25 |
Sarah Gheuens
CTO | Chief Tech/Sci/R&D Officer | 47 | 2021-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 66 | 2014-12-08 | |
May Kin Ho
BRD | Director/Board Member | 73 | 2015-06-22 |
David Scadden
BRD | Director/Board Member | 73 | 2017-05-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/4/26 | Sell | Chief Technology Officer | -30,000 | 0.0504% | ||
| 7/8/26 | Free | Director | 2,894 | 0.0049% | ||
| 7/1/26 | Exercice | Chief Technology Officer | 20,757 | 0.0349% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.20% | +3.79% | -11.72% | +90.44% | 2.27B | |
| -3.10% | -4.19% | +32.67% | +59.47% | 63.48B | |
| +0.79% | +0.31% | +10.75% | +80.38% | 54.55B | |
| -0.88% | +1.19% | +10.66% | +102.57% | 53.59B | |
| -0.75% | +1.38% | +24.89% | +50.91% | 44.75B | |
| -1.30% | -4.80% | +16.05% | +114.76% | 41.62B | |
| +1.26% | -5.26% | +221.12% | +900.64% | 39.91B | |
| -0.74% | -4.46% | +11.00% | +44.65% | 32.47B | |
| +0.58% | +14.96% | +61.29% | +51.28% | 26.7B | |
| +3.72% | -6.23% | +26.01% | -8.28% | 23.36B | |
| Average | +0.28% | -0.70% | +40.27% | +148.68% | 38.27B | |
| Weighted average by Cap. | -0.40% | -1.24% | +42.89% | +155.45% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 177M 159M 146M 133M 248M 16.79B 251M 1.76B 697M 8.8B 663M 649M 27.9B | 345M 310M 286M 260M 485M 32.8B 491M 3.43B 1.36B 17.19B 1.3B 1.27B 54.53B |
| Net income | -343M -308M -284M -258M -482M -32.59B -488M -3.41B -1.35B -17.08B -1.29B -1.26B -54.17B | -234M -210M -194M -176M -329M -22.26B -333M -2.33B -925M -11.67B -880M -861M -37B |
| Net Debt | -133M -120M -111M -100M -187M -12.67B -190M -1.33B -526M -6.64B -501M -490M -21.07B | -18.27M -16.4M -15.14M -13.73M -25.66M -1.74B -25.98M -182M -72.1M -910M -68.58M -67.12M -2.88B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-27 | US$38.03 | +3.20% | 739,087 |
| 26-10-26 | US$36.85 | -0.41% | 838,543 |
| 26-10-23 | US$37.00 | -0.51% | 920,052 |
| 26-10-22 | US$37.19 | +0.03% | 931,101 |
| 26-10-21 | US$37.18 | +1.47% | 849,888 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AGIO Stock
Select your edition
All financial news and data tailored to specific country editions
